Jupiter Life Line Hospitals enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023


1,705	—	—	—	—
430	540	483	318	136
0.2	0.0	0.0	0.0	—
509	509	326	0.0	—
1,784	—	—	—	—
78.7	−31.9	−157	−318	—
₹272.13	—	—	—	—

2,139	2,053	1,682	1,169	—
23.8%	24.8%	19.4%	0.0%	—
0.29×	—	—	—	—

1.10×	—	—	—	—
4.97×	—	—	—	—
6.89×	—	—	—	—
1,621	1,500	1,262	1,070	893
359	343	297	238	201
259	256	240	196	163
—	268	253	115	—
−234	−234	−67.4	29.2	—
—	−240	−69.3	26.7	—
—	502	321	85.3	77.2

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

JLHL₹260.10

Jupiter Life Line Hospitals Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH KIMS HCG MARKSANS METROPOLIS PARKHOSPS CORONAMcap ₹1,705 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	1,705.4
- Cash, Equiv & ST Investments	135.9	318.1	482.6	540.5	429.8
+ Minority Interest	—	0.0	0.0	0.0	0.2
+ Total Debt	—	0.0	325.7	508.5	508.5
Enterprise Value	—	—	—	—	1,784.3
Net Debt (memo)	—	-318.1	-156.9	-31.9	78.7
EV per Share	—	—	—	—	272.13

Total Capital	—	1,168.7	1,682.0	2,052.6	2,139.1
Total Debt/Total Capital	—	0.00	19.37	24.77	23.77
Total Debt/EV	—	—	—	—	0.29

EV/Sales	—	—	—	—	1.10
EV/EBITDA	—	—	—	—	4.97
EV/EBIT	—	—	—	—	6.89
Reference Items — Trailing FY Values
Sales	892.5	1,069.5	1,261.5	1,499.8	1,620.7
EBITDA	201.3	238.2	296.6	343.3	358.7
EBIT	162.8	195.8	239.6	255.6	258.8
Operating Cash Flow	—	114.5	253.3	267.7	—
Free Cash Flow	—	29.2	-67.4	-234.1	-234.1
FCFF (free cash flow to the firm)	—	26.7	-69.3	-240.0	—
Capital Expenditure	77.2	85.3	320.7	501.8	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.